spacer
The Healthcare Sales & Marketing Network celebrates 28 years serving the medical sales & marketing community.Connecting Medical Sales Reps with MedTech/BioPharma Recruiters and Independent Reps with and New Product LinesConnecting Medical Sales Reps with MedTech/BioPharma Recruiters and Independent Reps with and New Product Lines

Healthcare News Roundup: Biopharmaceutical

 HSMN NewsFeed - 25 Apr 2008
European Commission Approves Viread(R) for Chronic Hepatitis B
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 25 Apr 2008
FDA Provides Clarity to Isis Regarding the Development Path for Mipomersen
Biopharmaceuticals FDA
 HSMN NewsFeed - 25 Apr 2008
Neupro(R) recommended for approval in Europe for Restless Legs Syndrome
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 24 Apr 2008
Genentech Announces Decision in Contract Dispute
Biopharmaceuticals Litigation
 HSMN NewsFeed - 24 Apr 2008
Wyeth and Progenics Receive Positive Opinion From European Committee for RELISTOR for the Treatment of Opioid-Induced Constipation in Advanced-Illness Patients
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 24 Apr 2008
Hana Biosciences Appoints Anne E. Hagey, M.D., Vice President and Chief Medical Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 24 Apr 2008
Two Merck Medicines Recommended for Approval in the European Union
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 24 Apr 2008
Jerini Receives Positive CHMP Opinion Recommending European Approval for Icatibant in the Treatment of HAE; FDA Issues Not Approvable Letter
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 24 Apr 2008
European Medicines Agency Adopts Positive Opinion for Ranolazine for Treatment of Chronic Angina
Biopharmaceuticals Cardiology Regulatory
 HSMN NewsFeed - 24 Apr 2008
Lannett Company Receives Approval for Dipyridamole Tablets USP, 25 mg, 50 mg, and 75 mg
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 24 Apr 2008
Dr Michael Rosenblatt Appointed Non-Executive Director at Shire
Biopharmaceuticals Personnel
 HSMN NewsFeed - 24 Apr 2008
Latona Announces the Acquistion of Patent Rights and Orphan Drug Status to Novel Late Stage Drug Compound for Juvenile and Adult Rheumatoid Arthritis
Biopharmaceuticals Licensing
 HSMN NewsFeed - 24 Apr 2008
Transdel Pharmaceuticals Appoints Chief Medical Officer and Chief Operating Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 24 Apr 2008
Jerini AG -- FDA Issues Not Approvable Letter for Icatibant in the Treatment of HAE
Biopharmaceuticals FDA
 HSMN NewsFeed - 24 Apr 2008
Cephalon Notified of Generic Fentanyl Buccal Tablet Filing
Biopharmaceuticals Generics
 HSMN NewsFeed - 24 Apr 2008
CardioVascular BioTherapeutics, Inc. Funding Wound Healing Trial with R&D Partnership
Biopharmaceuticals
 HSMN NewsFeed - 24 Apr 2008
King Pharmaceuticals and Acura Pharmaceuticals Announce Completion of Patient Enrollment for Pivotal Phase III Clinical Trial Evaluating ACUROX(TM)
Biopharmaceuticals
 HSMN NewsFeed - 24 Apr 2008
Dyax Corp. and Cubist Pharmaceuticals, Inc. Sign Development and Commercialization Agreement for DX-88 Surgical Indications
Biopharmaceuticals
 HSMN NewsFeed - 24 Apr 2008
Akorn-Strides, LLC Announces FDA Approvals for Ondansetron Injection USP, 4 mg/2mL Single Dose Vials and Ondansetron Injection USP, 40 mg/20mL Multiple Dose Vials
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 24 Apr 2008
Veteran Drug Industry Executive to Become President of CTI
Biopharmaceuticals Personnel
 HSMN NewsFeed - 23 Apr 2008
FDA Approves VYVANSE(TM) (lisdexamfetamine dimesylate), the First and Only Once-Daily Prodrug Stimulant to Treat ADHD in Adults
Biopharmaceuticals FDA
 HSMN NewsFeed - 23 Apr 2008
Aldagen Secures $18.4 Million in Financing
Biopharmaceuticals Regenerative Medicine Venture Capital
 HSMN NewsFeed - 23 Apr 2008
Metabasis Therapeutics Announces Extension of Its Collaboration with Merck & Co., Inc. to Develop AMPK Activators for Diabetes and Other Metabolic Diseases
Biopharmaceuticals
 HSMN NewsFeed - 23 Apr 2008
Argos Therapeutics Secures $35.2 Million Series C Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 23 Apr 2008
InSite Vision Appoints New Vice President of Operations
Biopharmaceuticals Ophthalmology Personnel
 HSMN NewsFeed - 23 Apr 2008
Oculus Innovative Sciences Appoints Michelle Carpenter, JD, RAC, as Vice President of Regulatory Affairs and Quality
Biopharmaceuticals Wound Care Personnel
 HSMN NewsFeed - 23 Apr 2008
FDA Approval of Cimzia(R) for Crohn's Disease Represents Latest Milestone for Nektar's PEGylation Technology Platform
Biopharmaceuticals Gastroenterology FDA
 HSMN NewsFeed - 23 Apr 2008
MacroChem Acquires Virium Pharmaceuticals
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 23 Apr 2008
Abraxis BioScience Reports Promising Clinical Data in Advanced Pancreatic Cancer Using a Combination of nab-Paclitaxel (ABRAXANE(R)) and Gemcitabine (Gemzar(R))
Biopharmaceuticals Oncology
 HSMN NewsFeed - 23 Apr 2008
Ceregene Announces Two Key Additions to Leadership Team
Biopharmaceuticals Personnel
 HSMN NewsFeed - 22 Apr 2008
GlaxoSmithKline to Acquire Sirtris Pharmaceuticals, a World Leader in 'Sirtuin' Research and Development
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 22 Apr 2008
Cimzia(R) Approved in the US for the Treatment of Moderate to Severe Crohn's Disease
Biopharmaceuticals Gastroenterology FDA
 HSMN NewsFeed - 22 Apr 2008
NCCN Updates Non-Hodgkin's Lymphoma Guidelines
Biopharmaceuticals Oncology
 HSMN NewsFeed - 22 Apr 2008
Cambria Pharmaceuticals Announces $5.4 Million Series A Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 22 Apr 2008
Resolvyx Pharmaceuticals Strengthens Its Board of Directors with Industry Leaders
Biopharmaceuticals Personnel
 HSMN NewsFeed - 22 Apr 2008
Resolvyx Pharmaceuticals Raises $25 Million in Series B Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 22 Apr 2008
Synthetic Blood International, Inc. to Seek Shareholder Approval for Name Change
Biopharmaceuticals
 HSMN NewsFeed - 22 Apr 2008
Archemix' ARC1779 Granted Orphan Designation for the Treatment of TTP, a Life-Threatening Blood Disorder
Biopharmaceuticals FDA
 HSMN NewsFeed - 22 Apr 2008
ImClone Announces Agreement with FDA on Special Protocol Assessment for Phase III Study of IMC-1121B in Breast Cancer
Biopharmaceuticals Oncology
 HSMN NewsFeed - 22 Apr 2008
CuraGen Sells Ownership of Belinostat to TopoTarget A/S
Biopharmaceuticals
 HSMN NewsFeed - 22 Apr 2008
Pfizer Japan to Launch Champix(R) the First Prescription Oral Smoking Cessation Aid in Japan
Biopharmaceuticals
 HSMN NewsFeed - 21 Apr 2008
DUSA Pharmaceuticals Chairman Role Expected to Change Due to Serious Illness
Biopharmaceuticals Personnel
 HSMN NewsFeed - 21 Apr 2008
Alpharma to Withdraw and Resubmit Its New Drug Application for EMBEDA(TM)
Biopharmaceuticals
 HSMN NewsFeed - 21 Apr 2008
VIVUS Appoints Charles J. Casamento to the Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 21 Apr 2008
Genzyme Provides Update on Myozyme(R) Manufacturing
Biopharmaceuticals
 HSMN NewsFeed - 21 Apr 2008
High-Dose Lipitor Reduced the Risk of Heart Attack and Stroke in Patients with Chronic Kidney Disease
Biopharmaceuticals Cardiology
 HSMN NewsFeed - 21 Apr 2008
Pfizer Japan Receives Manufacturing and Marketing Authorization for SUTENT
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 21 Apr 2008
Mylan Announces Final FDA Approval for Felodipine Extended-Release Tablets, USP
Biopharmaceuticals FDA Generics
 HSMN NewsFeed - 21 Apr 2008
Biovail Strengthens Leadership Team
Biopharmaceuticals Drug Delivery Personnel
 HSMN NewsFeed - 21 Apr 2008
InterMune Announces Progress on Pirfenidone in IPF
Biopharmaceuticals
 HSMN NewsFeed - 21 Apr 2008
APP Pharmaceuticals Receives FDA Approval for Colistimethate For Injection, USP
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 21 Apr 2008
Watson Files FDA Application for Generic YASMIN(R)
Biopharmaceuticals Generics
 HSMN NewsFeed - 21 Apr 2008
Thalidomide Pharmion(TM) Granted Full Marketing Authorization for Treatment of Newly Diagnosed Multiple Myeloma in the European Union
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 21 Apr 2008
Graceway Pharmaceuticals Reports Study in New England Journal of Medicine: ALDARA(R) (imiquimod) Cream, 5% demonstrated a reduction in lesion size in patients with vulvar intraepithelial neoplasia (VIN)
Biopharmaceuticals
 HSMN NewsFeed - 21 Apr 2008
Genentech Provides Update on ''AVAiL'' Phase III Study of Avastin Plus Chemotherapy in First-Line, Advanced, Non-Squamous, Non-Small Cell Lung Cancer
Biopharmaceuticals Oncology
 HSMN NewsFeed - 18 Apr 2008
Genomics Likely to Replace Traditional Drug Therapies in Treating CHF
Biopharmaceuticals Cardiology
 HSMN NewsFeed - 18 Apr 2008
Caraco Pharmaceutical Laboratories Ltd. Wins Summary Judgment on Generic Ultracet(R)
Biopharmaceuticals Generics Litigation
 HSMN NewsFeed - 18 Apr 2008
Akorn, Inc. Announces FDA Approval of Diclofenac Sodium Ophthalmic Solution 0.1%
BIopharmaceuticals Generics Ophthalmology FDA
 HSMN NewsFeed - 18 Apr 2008
Addex Appoints Laurent Massuyeau as Head of Business Development
Biopharmaceuticals Personnel
 HSMN NewsFeed - 17 Apr 2008
Zogenix Completes Management Team with Cynthia Robinson, Ph.D., CDO, & Mark Thompson, VP, Sales & Managed Markets
Biopharmaceuticals Drug Delivery Personnel
 HSMN NewsFeed - 17 Apr 2008
Dynavax and Merck & Co., Inc. Update Status of Clinical Hold of Investigational Vaccine HEPLISAV(TM)
Biopharmaceuticals FDA
 HSMN NewsFeed - 17 Apr 2008
Biogen Idec Announces Slate of Directors for Annual Meeting of Shareholders
Biopharmaceuticals Personnel
 HSMN NewsFeed - 17 Apr 2008
Alseres Pharmaceuticals Expands Sites for the First Stage of the ALTROPANE(R) Phase III Clinical Trial Program
Biopharmaceuticals Diagnostics Neurology
 HSMN NewsFeed - 17 Apr 2008
Arpida Provides Comprehensive Overview of Pivotal Phase III Trial Data
Biopharmaceuticals
 HSMN NewsFeed - 17 Apr 2008
Teva Announces Tentative Approval of Generic Maxalt(R) Tablets
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 17 Apr 2008
Schering-Plough Highlights PEGINTRON(TM) and Boceprevir Data Presentations at European Association for the Study of the Liver (EASL) Annual Meeting
Biopharmaceuticals
 HSMN NewsFeed - 17 Apr 2008
Eisai Corporation of North America Announces Appointment of Vice President of U.S. Corporate Communications
Biopharmaceuticals Personnel
 HSMN NewsFeed - 17 Apr 2008
John D. Baxter, M.D. Joins Bionovo's Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 17 Apr 2008
Angiotech's novel 5-FU Central Venous Catheter receives FDA 510(k) clearance
Biopharmaceuticals Devices FDA
 HSMN NewsFeed - 17 Apr 2008
Accentia Announces that After Reviewing Unblinded Results, Independent DMC Recommends Presenting Data on BiovaxID(R) to FDA and Worldwide Regulatory Agencies in Order to Seek Marketing Approvals for Follicular Non-Hodgkin's Lymphoma
Biopharmaceuticals Oncology
 HSMN NewsFeed - 17 Apr 2008
Biovest Reports that Independent Data Monitoring Committee Recommends Unblinding of Phase 3 Clinical Results for its Anti-Cancer Vaccine, BiovaxID(R)
Biopharmaceuticals Oncology
 HSMN NewsFeed - 17 Apr 2008
New Data Confirm Pramipexole (Mirapexin(R)/Sifrol(R)) Can Significantly Reduce Sleep Disturbance for People With Restless Legs Syndrome (RLS)
Biopharmaceuticals
 HSMN NewsFeed - 16 Apr 2008
Schering-Plough Announces Imperfect Contraceptive Use Impacts Women's Emotional Well-Being
Biopharmaceuticals
 HSMN NewsFeed - 16 Apr 2008
Lilly to Streamline Indianapolis Manufacturing and Engineering Operations
Biopharmaceuticals
 HSMN NewsFeed - 16 Apr 2008
European Regulatory Agency Grants Orphan Status to Morphotek(R)'s Farletuzumab and MORAb-009
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 16 Apr 2008
Chemokine Therapeutics Announces New President And Chief Executive Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 16 Apr 2008
Javelin Pharmaceuticals Appoints John C. Taylor as Vice President of Business Development
Biopharmaceuticals Personnel
 HSMN NewsFeed - 16 Apr 2008
Lyrica Reduced Pain of Fibromyalgia in Patients Regardless of Symptoms of Anxiety or Depression
Biopharmaceuticals Neurology
 HSMN NewsFeed - 16 Apr 2008
Graceway Pharmaceuticals Reports Study in British Journal of Dermatology: Patients Treated with ALDARA Experienced Higher Levels of Histological and Sustained Clearance for Actinic Keratosis (AK) than Patients in two Other Common AK Treatments
Biopharmaceuticals Dermatology
 HSMN NewsFeed - 16 Apr 2008
CoNCERT Pharmaceuticals Announces Appointment of Justine Koenigsberg as Senior Director, Corporate Communications and Investor Relations
Biopharmaceuticals Personnel
 HSMN NewsFeed - 16 Apr 2008
Abbott Announces HUMIRA(R) (adalimumab) Approved in Japan for the Treatment of Rheumatoid Arthritis
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 16 Apr 2008
Akorn, Inc. Announces FDA Approval of Ofloxacin Ophthalmic Solution USP, 0.3%
Biopharmaceuticals Generics FDA Ophthalmology
 HSMN NewsFeed - 16 Apr 2008
Merck Announces Planned Investment of $50 Million in Research Center in the US
Biopharmaceuticals
 HSMN NewsFeed - 15 Apr 2008
Treximet(TM) (Sumatriptan and Naproxen Sodium) Tablets Approved by FDA for Acute Treatment of Migraine
Biopharmaceuticals FDA
 HSMN NewsFeed - 15 Apr 2008
Alcon's PATANASE(R) Nasal Spray Approved by FDA for Treatment of Nasal Allergy Symptoms
Biopharmaceuticals FDA
 HSMN NewsFeed - 15 Apr 2008
Santarus Provides Termination Notice to Otsuka America Pharmaceutical for ZEGERID Co-Promotion Agreement
Biopharmaceuticals
 HSMN NewsFeed - 15 Apr 2008
CV Therapeutics Announces $185 Million Transaction with TPG-Axon Capital for Half of Royalty for Lexiscan(TM) (regadenoson) Injection
Biopharmaceuticals
 HSMN NewsFeed - 15 Apr 2008
Merck Responds to Journal of the American Medical Association Articles
Biopharmaceuticals
 HSMN NewsFeed - 15 Apr 2008
Biogen Idec and Elan Present New TYSABRI(R) Data at the 60th Annual Meeting of the American Academy of Neurology
Biopharmaceuticals Neurology
 HSMN NewsFeed - 15 Apr 2008
Phytomedics Inc. Appoints Dr. Laurie Smaldone Alsup, MD., as President and Chief Executive Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 15 Apr 2008
Diasome Pharmaceuticals Announces Series B Financing
Biopharmaceuticals Endocrinology Venture Capital
 HSMN NewsFeed - 15 Apr 2008
Anaphore, Inc Receives $8M Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 15 Apr 2008
Ranbaxy and AstraZeneca Reach Agreement in Esomeprazole Patent Litigation
Biopharmaceuticals Generics Litigation Distribution
 HSMN NewsFeed - 15 Apr 2008
Study Shows that High-Dose, High-Frequency Interferon Produces no Additional Benefit on Efficacy Compared to AVONEX(R) (interferon beta-1a) in Patients with Relapsing-Remitting Multiple Sclerosis (RRMS)
Biopharmaceuticals Neurology
 HSMN NewsFeed - 15 Apr 2008
BioSante Pharmaceuticals Appoints Michael C. Snabes, M.D., PhD, Vice President, Clinical Development
Biopharmaceuticals Personnel
 HSMN NewsFeed - 15 Apr 2008
Lev Pharmaceuticals Announces Submission of Complete Response to FDA for Cinryze(TM) for Hereditary Angioedema
Biopharmaceuticals
 HSMN NewsFeed - 15 Apr 2008
Kiadis Pharma Receives Orphan Drug Designation for Rhitol(TM) From the FDA
Biopharmaceuticals FDA
 HSMN NewsFeed - 15 Apr 2008
Heritage Announces $10 Million Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 15 Apr 2008
Medivir Enters Co-Promotion Agreement with GlaxoSmithKline (GSK)
Biopharmaceuticals
 HSMN NewsFeed - 14 Apr 2008
Artes Medical Reports Over Seven Thousand Patients Treated with ArteFill since February 2007 Product Launch
Biopharmaceuticals Dermatology
 HSMN NewsFeed - 14 Apr 2008
Vasogen Announces Implementation of Strategic Restructuring Plan
Biopharmaceuticals
 HSMN NewsFeed - 14 Apr 2008
VioQuest Pharmaceuticals Names Vernon L. Alvarez, Ph.D. as Vice President, Research & Development and Announces Resignation of Chief Scientific Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 14 Apr 2008
Cephalon Announces European Commission Approval of EFFENTORA for the Treatment of Breakthrough Cancer Pain
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 14 Apr 2008
Jazz Pharmaceuticals' LUVOX CR Is Now Available for Patients With Social Anxiety Disorder (SAD) and Obsessive Compulsive Disorder (OCD)
Biopharmaceuticals
 HSMN NewsFeed - 14 Apr 2008
KV Begins Shipping Evamist(TM) to Wholesalers
Biopharmaceuticals
 HSMN NewsFeed - 14 Apr 2008
AtheroGenics Announces Encouraging Interim Results From Phase 3 Clinical Trial of AGI-1067 in Type 2 Diabetes
Biopharmaceuticals Endocrinology
 HSMN NewsFeed - 14 Apr 2008
Low HER2 Expressing Breast Cancer Patients Respond Preferentially to Apthera's NeuVax(TM)
Biopharmaceuticals Oncology
 HSMN NewsFeed - 14 Apr 2008
Meda and Orexo in a Potential Billion SEK Deal
Biopharmaceuticals Acquisitions
 HSMN NewsFeed - 11 Apr 2008
Endo Announces Executive Appointment
Biopharmaceuticals Personnel
 HSMN NewsFeed - 11 Apr 2008
AEterna Zentaris Announces Changes to its Management Team
Biopharmaceuticals Personnel
 HSMN NewsFeed - 11 Apr 2008
Amrubicin is Designated as an Orphan Medicinal Product by the European Commission for the Treatment of Small Cell Lung Cancer
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 11 Apr 2008
PDI Signs Promotion Agreement with Major Pharmaceutical Company
Biopharmaceuticals
 HSMN NewsFeed - 11 Apr 2008
Status of the E2007 (perampanel) Development Program - Termination of Parkinson's Disease Clinical Development and Focus on Neuropathic Pain and Epilepsy Indications
Biopharmaceuticals
 HSMN NewsFeed - 11 Apr 2008
ALIMTA(R) (pemetrexed for injection) Receives European Approval for Histologically-Based Use in First-Line Treatment of Most Common Lung Cancer
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 10 Apr 2008
Leslie J. Browne Resigns as President and Chief Executive Officer of Pharmacopeia, Inc.
Biopharmaceuticals Personnel
 HSMN NewsFeed - 10 Apr 2008
COPAXONE(R) Significantly Reduced Annual Relapse Rates and Stabilized Disease Progression in Relapsing Remitting Multiple Sclerosis Patients Failing Interferon Treatment
Biopharmaceuticals Neurology
 HSMN NewsFeed - 10 Apr 2008
Hi-Tech Pharmacal Receives Tentative Approval for Dorzolamide Hydrochloride with Timolol Maleate Ophthalmic Solution
Biopharmaceuticals Generics Ophthalmology FDA
 HSMN NewsFeed - 10 Apr 2008
MannKind Addresses Pfizer's Announcement Regarding Exubera
Biopharmaceuticals Drug Delivery Endocrinology Oncology
 HSMN NewsFeed - 10 Apr 2008
Symbollon Pharmaceuticals Announces Results of IoGen Phase III Clinical Trial
Biopharmaceuticals
 HSMN NewsFeed - 10 Apr 2008
Celera Grants License to Merck & Co., Inc. for Cancer Targets
Biopharmaceuticals Oncology Licensing
 HSMN NewsFeed - 10 Apr 2008
Millennium Announces VELCADE(R) (Bortezomib) for Injection First-Quarter 2008 U.S. Net Sales
Biopharmaceuticals Oncology
 HSMN NewsFeed - 10 Apr 2008
Takeda to Acquire Millennium for US$25.00 Per Share in an All Cash Tender Offer Valued at $8.8 Billion
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 9 Apr 2008
Stemline Therapeutics Raises $12.5 Million
Biopharmaceuticals Oncology Venture Capital
 HSMN NewsFeed - 9 Apr 2008
Tetraphase Pharmaceuticals Announces Appointment of Guy Macdonald as President and Chief Executive Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 9 Apr 2008
Nektar Terminates All Negotiations With Potential Partners for Inhaled Insulin; Increased Number of Lung Cancer Cases Observed in Ongoing Clinical Studies of Inhaled Insulin Patients
Biopharmaceuticals Endocrinology Oncology
 HSMN NewsFeed - 9 Apr 2008
Novacea Receives Notification From Schering-Plough of Termination of Collaboration Agreement
Biopharmaceuticals
 HSMN NewsFeed - 9 Apr 2008
Pfizer Statement on Exubera Labeling Update in the United States
Biopharmaceuticals Endocrinology Oncology
 HSMN NewsFeed - 9 Apr 2008
Abraxis BioScience Announces Approval to Market ABRAXANE for Metastatic Breast Cancer in Korea
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 9 Apr 2008
ADVENTRX Appoints Vice President of Manufacturing
Biopharmaceuticals Personnel
 HSMN NewsFeed - 9 Apr 2008
Novagali Pharma Announces the Launch of Cationorm(R)
Biopharmaceuticals Ophthalmology
 HSMN NewsFeed - 8 Apr 2008
Lorus Therapeutics Announces Exclusive Multinational License Agreement with Zoticon Bioventures for Virulizin(R)
Biopharmaceuticals Oncology Licensing
 HSMN NewsFeed - 8 Apr 2008
U.S. Food and Drug Administration Approves ORENCIA(R) (abatacept) for the Treatment of Moderate-to-Severe Polyarticular Juvenile Idiopathic Arthritis (JIA) in Patients Six Years and Older
Biopharmaceuticals FDA
 HSMN NewsFeed - 8 Apr 2008
Inotek Focuses Resources on Clinical Programs, Adds to Executive Management Team and Consolidates Operations in Massachusetts
Biopharmaceuticals Personnel
 HSMN NewsFeed - 8 Apr 2008
GlaxoSmithKline Confirms Receipt of FDA Letter on Regulatory Reporting
Biopharmaceuticals FDA
 HSMN NewsFeed - 8 Apr 2008
DiaMedica Announces Changes to Board of Directors and Corporate Officers
Biopharmaceuticals Personnel
 HSMN NewsFeed - 8 Apr 2008
Collegium Pharmaceutical Announces FDA Filing for AllerNase(TM), a Nasal Inhaled Steroid for the Treatment of Allergic Rhinitis
Biopharmaceuticals FDA
 HSMN NewsFeed - 8 Apr 2008
Repligen Announces Settlement with Bristol-Myers Squibb in Orencia(R) Lawsuit
Biopharmaceuticals Litigation
 HSMN NewsFeed - 8 Apr 2008
Anesiva Announces Pivotal Phase 3 Clinical Trial of Adlea(TM) for Reducing Post-Surgical Pain Following Total Knee Replacement
Biopharmaceuticals
 HSMN NewsFeed - 8 Apr 2008
Oncophage(R) Approved in Russia for the Treatment of Intermediate-Risk Kidney Cancer
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 8 Apr 2008
New York Medicaid Program Establishes Coverage for Trofile(TM)
Diagnostics Biopharmaceuticals HIV/AIDS Reimbursement
 HSMN NewsFeed - 8 Apr 2008
Bristol-Myers Squibb and Otsuka Receive European Marketing Authorisation for ABILIFY(R) in the Treatment and Prevention of Moderate to Severe Manic Episodes in Bipolar I Disorder
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 7 Apr 2008
Endo Pharmaceuticals Provides Updates on FROVA(R) and CHRONOGESIC(R) Clinical Development Programs
Biopharmaceuticals
 HSMN NewsFeed - 7 Apr 2008
Microbia Announces Name Change to Ironwood Pharmaceuticals
Biopharmaceuticals
 HSMN NewsFeed - 7 Apr 2008
Stiefel Laboratories Appoints First Chief Scientific Officer
Biopharmaceuticals Dermatology Personnel
 HSMN NewsFeed - 7 Apr 2008
Keryx Biopharmaceuticals Announces Implementation of Strategic Restructuring Plan
Biopharmaceuticals
 HSMN NewsFeed - 7 Apr 2008
Quark Pharmaceuticals, Inc. Closes $27 Million Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 7 Apr 2008
TargetRx Completes $9.6M Financing Round
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 7 Apr 2008
Thalidomide Pharmion(R) Receives Marketing Approval from Australian Therapeutic Goods Administration for Treatment of Newly Diagnosed Multiple Myeloma
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 7 Apr 2008
Biopure Receives Comment Letter From U.K. Regulatory Body on Marketing Application for Hemopure(R)
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 7 Apr 2008
New Abbott Kaletra(R) (lopinavir/ritonavir) Lower-Strength Tablet for Pediatric Use Approved in Europe
Biopharmaceuticals Regulatory HIV/AIDS
 HSMN NewsFeed - 7 Apr 2008
Novartis to further strengthen its healthcare portfolio by acquiring 25% stake in Alcon from Nestlé with right to take over majority ownership of the world leader in eye care
Biopharmaceuticals Ophthalmology Mergers & Acquisitions
 HSMN NewsFeed - 4 Apr 2008
VIVUS Enters into $30 Million Funding Collaboration for the Phase 3 Studies of Avanafil for Erectile Dysfunction
Biopharmaceuticals
 HSMN NewsFeed - 4 Apr 2008
Synthetic Blood International, Inc. Announces Plans to File Protocol for Phase II-b Oxycyte(R) Clinical Trial
Biopharmaceuticals Neurosurgery
 HSMN NewsFeed - 3 Apr 2008
FDA Approves Rotarix(R) [Rotavirus Vaccine, Live, Oral], the First Vaccine Licensed to Complete the Rotavirus Immunization Series by Four Months of Age
Biopharmaceuticals FDA
 HSMN NewsFeed - 3 Apr 2008
Medicure Comments on Positive AGGRASTAT Results Presented at the American College of Cardiology Annual Scientific Session
Biopharmaceuticals Cardiology
 HSMN NewsFeed - 3 Apr 2008
Alba Therapeutics Announces Appointment of Bruce A. Peacock as its Chief Executive Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 3 Apr 2008
Nabi Biopharmaceuticals Announces Settlement of Litigation
Biopharmaceuticals Litigation
 HSMN NewsFeed - 3 Apr 2008
Akorn, Inc. Signs Supply Agreement with Fresenius Kabi for Premix Product
Biopharmaceuticals
 HSMN NewsFeed - 3 Apr 2008
Excipients Help Pharma Extend Product Life, Profits
Biopharmaceuticals Drug Delivery
 HSMN NewsFeed - 3 Apr 2008
Derma Sciences Closes $6.1 Million Private Placement
Biopharmaceuticals Wound Care Venture Capital
 HSMN NewsFeed - 3 Apr 2008
Medarex Announces Ipilimumab Program Continues to Move Forward
Biopharmaceuticals Oncology
 HSMN NewsFeed - 3 Apr 2008
Acorda Therapeutics Names John Librie Senior Vice President, Sales and Marketing
Biopharmaceuticals Personnel
 HSMN NewsFeed - 3 Apr 2008
Taro Receives Tentative FDA Approval for Lamotrigine Tablets ANDA
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 3 Apr 2008
Dr. Reddy's Acquires Jet Generici Srl
Biopharmaceuticals Generics Acquisitions
 HSMN NewsFeed - 3 Apr 2008
Asuragen Launches Mirna Therapeutics
Diagnostics Biopharmaceuticals
 HSMN NewsFeed - 2 Apr 2008
Pivotal Phase 3 Data Show Denosumab Increased Bone Density at Multiple Skeletal Sites in Early and Later Stage Postmenopausal Women
Biopharmaceuticals
 HSMN NewsFeed - 2 Apr 2008
Alfacell Updates Status of ONCONASE(R) Phase III Clinical Program
Biopharmaceuticals Oncology
 HSMN NewsFeed - 2 Apr 2008
Genta Restructures Operations to Focus on Priority Initiatives
Biopharmaceuticals
 HSMN NewsFeed - 2 Apr 2008
Sirtris Receives Orphan Drug Designation from U.S. Food and Drug Administration for Resveratrol in Mitochondrial Disorder, MELAS Syndrome
Biopharmaceuticals FDA
 HSMN NewsFeed - 2 Apr 2008
Bradmer announces new additions to management team
Biopharmaceuticals Personnel
 HSMN NewsFeed - 2 Apr 2008
Kamada Announces That It Had Successfully Met the Primary Endpoint in Its US Phase III Clinical Trial with Intravenous AAT
Biopharmaceuticals
 HSMN NewsFeed - 2 Apr 2008
European Regulatory Agency Accepts Cell Therapeutics, Inc.'s Marketing Authorization Application for XYOTAX(TM) for Lung Cancer for Review
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 1 Apr 2008
Pfizer Announces Discontinuation of Phase III Clinical Trial for Patients with Advanced Melanoma
Biopharmaceuticals Oncology
 HSMN NewsFeed - 1 Apr 2008
CV Therapeutics' Anti-Ischemic Therapy Ranexa(R) Significantly Reduces Cardiac Chest Pain Symptoms and Recurrent Ischemia in MERLIN-TIMI 36 Patients With Angina
Biopharmaceuticals Cardiology
 HSMN NewsFeed - 1 Apr 2008
Medicure Announces MEND-CABG II Study Results at the American College of Cardiology Annual Scientific Session
Biopharmaceuticals Cardiology
 HSMN NewsFeed - 1 Apr 2008
Lipitor Provided an Unexpectedly Potent Heart Benefit in Patients with Chronic Stable Angina, According to New Study
Biopharmaceuticals Cardiology
 HSMN NewsFeed - 1 Apr 2008
MDS Pharma Services Names Teresa Winslow and James Miskel to Senior Team
Biopharmaceuticals Personnel
 HSMN NewsFeed - 1 Apr 2008
Supratek's lead compound SP1049C is granted Orphan Drug Designation for the treatment of gastric cancer.
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 1 Apr 2008
Labopharm Appeals FDA's Decision on Once-Daily Tramadol to Next Supervisory Level After Additional Analysis Supports Efficacy
Biopharmaceuticals FDA
 HSMN NewsFeed - 1 Apr 2008
Wyeth and Progenics Announce RELISTOR Receives Canadian Marketing Approval
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 1 Apr 2008
Ipsen: Appointment of Dominique Bridon, PhD as Vice President, Discovery
Biopharmaceuticals Personnel
 HSMN NewsFeed - 1 Apr 2008
SPP100 (Tekturna/Rasilez) Reduces Left Ventricular Hypertrophy
Biopharmaceuticals Cardiology
 HSMN NewsFeed - 1 Apr 2008
Dr. Reddy's Signs Definitive Agreement to Acquire Dowpharma Small Molecules Business Associated with Dow's Mirfield and Cambridge, UK Sites
Biopharmaceuticals Acquisitions
 HSMN NewsFeed - 31 Mar 2008
IMPAX Establishes Branded Products Division with Appointments of Senior Management
Biopharmaceuticals Personnel
 HSMN NewsFeed - 31 Mar 2008
Teva Provides Update on Generic Prevacid(R) Litigation
Biopharmaceuticals Generics Litigation
 HSMN NewsFeed - 31 Mar 2008
King Pharmaceuticals Presents Positive Results of CorVue(TM) Phase III Clinical Trials at the American College of Cardiology (ACC) Annual Scientific Conference
Biopharmaceuticals Radiology Cardiology
 HSMN NewsFeed - 31 Mar 2008
Spanish Appellate Court Rules in Pfizer's Favor, Upholds Lipitor Patent
Biopharmaceuticals Generics Litigation
 HSMN NewsFeed - 31 Mar 2008
Abbott's Phase III Studies of Investigational TriLipix(TM) (ABT-335), in Combination With Statins, Meets Primary Endpoints on Improving LDL, Triglycerides and HDL
Biopharmaceuticals Cardiology
 HSMN NewsFeed - 31 Mar 2008
New Data Showed ACTOS(R) (pioglitazone HCl) Prevented Progression of Atherosclerotic Plaque Volume in Patients With Type 2 Diabetes
Biopharmaceuticals Cardiology Endocrinology
 HSMN NewsFeed - 31 Mar 2008
Landmark Trial ONTARGET(R) Proves Telmisartan is as Protective as Ramipril and Better Tolerated in a Broad High-Risk Cardiovascular Population. From ONTARGET(R) it May be Concluded That Telmisartan can Prevent Every 5th Serious Cardiovascular Event
Biopharmaceuticals Cardiology
 HSMN NewsFeed - 31 Mar 2008
First Statin Monotherapy to Achieve Regression of Coronary Atherosclerosis by Angiography in a Major Clinical Study
Biopharmaceuticals Cardiology
 HSMN NewsFeed - 31 Mar 2008
Lotrel, a Single-Pill Combination for Treating High Blood Pressure, Reduced Cardiovascular Events by 20% in High-Risk Patients
Biopharmaceuticals Cardiology
 HSMN NewsFeed - 31 Mar 2008
Patients Treated with Merck's Investigational Extended-Release Niacin/Laropiprant (CORDAPTIVE(TM)) Reported Significantly Less Flushing Than Patients Treated with Niaspan(TM) in Phase III Study
Biopharmaceuticals Cardiology
 HSMN NewsFeed - 31 Mar 2008
TyRx Pharma, Inc. Announces the Appointment of Gary Young, PharmD, MBA as Vice President, Marketing
Biopharmaceuticals Personnel
 HSMN NewsFeed - 31 Mar 2008
Naglazyme Approved by Japanese Ministry of Health
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 31 Mar 2008
ACADIA Pharmaceuticals Initiates Second Phase III Trial with Pimavanserin in Patients with Parkinson's Disease Psychosis
Biopharmaceuticals
 HSMN NewsFeed - 31 Mar 2008
Synthetic Blood International, Inc. Announces New Leadership Roles to Continue Product Development Strategy
Biopharmaceuticals Personnel
 HSMN NewsFeed - 31 Mar 2008
Phase III Data Showed Taranabant, Merck's Investigational Medicine to Treat Obesity, Led to Statistically Significant Weight Loss
Biopharmaceuticals
 HSMN NewsFeed - 31 Mar 2008
Acusphere Licenses Hydrophobic Drug Delivery System to Cephalon for $10 Million
Biopharmaceuticals Drug Delivery Licensing
 HSMN NewsFeed - 31 Mar 2008
Update on ACHIEVE: A Study of Merck's Investigational Extended-Release Niacin/Laropiprant (CORDAPTIVE(TM))
Biopharmaceuticals Cardiology
 HSMN NewsFeed - 31 Mar 2008
ImClone Appoints Kenneth J. Zuerblis Chief Financial Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 31 Mar 2008
Teva to Acquire Bentley Pharmaceuticals
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 31 Mar 2008
Ranolazine Shortens QT Interval and Improves Cardiac Relaxation in Study of Patients With Genetic Sodium Channel Disorder
Biopharmaceuticals Cardiology
 HSMN NewsFeed - 31 Mar 2008
Lilly Launches Its First Phase III Trial for Treatment of Alzheimer's Disease
Biopharmaceuticals Neurology
 HSMN NewsFeed - 31 Mar 2008
BioAlliance Pharma Expands Its Loramyc(TM) Franchise by Signing a South East Asia Deal Worth up to $12 Million with the Leading Korean Pharma Company Handok
Biopharmaceuticals Licensing
 HSMN NewsFeed - 30 Mar 2008
Tekmira Pharmaceuticals and Protiva Biotherapeutics Announce Business Combination to Create Global Leader in RNAi Delivery and Therapeutics
Biopharmaceuticals
 HSMN NewsFeed - 30 Mar 2008
BRAVE-3 Questions Value of Abciximab in PCI for Heart Attack
Biopharmaceuticals Interventional Cardiology
 HSMN NewsFeed - 30 Mar 2008
Drug-Eluting Stents Outperform Bare Stents in Heart Attack
Biopharmaceuticals Interventional Cardiology
 HSMN NewsFeed - 29 Mar 2008
Study Results Show Investigational Drug, Prasugrel, Cuts Risk of Stent-Related Clots by More than Half Versus Clopidogrel
Biopharmaceuticals Interventional Cardiology
 HSMN NewsFeed - 29 Mar 2008
Tailored Clopidogrel Dosing Improves PCI Outcomes
Biopharmaceuticals Interventional Cardiology
 HSMN NewsFeed - 29 Mar 2008
Angiomax Demonstrated Improved Outcomes in Acute Heart Attack Patients Undergoing Primary Angioplasty Independent of Individual Risk Factors
Biopharmaceuticals Interventional Cardiology
 HSMN NewsFeed - 29 Mar 2008
ISAR-REACT 3 Pits Bivalirudin vs. Unfractionated Heparin in PCI
Biopharmaceuticals Interventional Cardiology
 HSMN NewsFeed - 28 Mar 2008
Teva Provides Update on Generic Aricept(R) Litigation
Biopharmaceuticals Generics Litigation Neurology
 HSMN NewsFeed - 28 Mar 2008
Positive results from Visudyne(R) combination therapy study reported at Annual Macula Society Conference
Biopharmaceuticals Ophthalmology
 HSMN NewsFeed - 28 Mar 2008
Barr Announces Reorganization of Senior Management, Business Functions
Biopharmaceuticals Personnel
 HSMN NewsFeed - 28 Mar 2008
Lannett Company Receives FDA Approval for Bethanechol Chloride Tablets USP, 5 mg, 10 mg, 25 mg, and 50 mg
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 28 Mar 2008
Actavis Receives Approval of Generic Wellbutrin SR(R) and Zyban(R) Tablets in the U.S.
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 28 Mar 2008
VaxGen and Raven Terminate Merger Agreement
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 28 Mar 2008
BioMimetic Therapeutics Addresses FDA Communication on Regranex Safety Review
Biopharmaceuticals Wound Care
 HSMN NewsFeed - 27 Mar 2008
Graceway Pharmaceuticals Files False Advertising and Unfair Competition Litigation Against River's Edge Pharmaceuticals
Biopharmaceuticals Litigation
 HSMN NewsFeed - 27 Mar 2008
EKR Therapeutics Announces Management Additions and Promotions, Reflecting Support of Continued Acceleration in Growth
Biopharmaceuticals Personnel
 HSMN NewsFeed - 27 Mar 2008
EKR Therapeutics Appoints Co-Founder Richard DeSimone as COO
Biopharmaceuticals Personnel
 HSMN NewsFeed - 27 Mar 2008
Pegintron(TM) Plus Weight-Based Rebetol(R) Resulted in Higher SVR Than Flat Dosing; Low Relapse Rates in Patients With Chronic Hepatitis C
Biopharmaceuticals FDA
 HSMN NewsFeed - 27 Mar 2008
Pfizer Clears U.S. Antitrust Review for Acquisition of All Outstanding Shares of Encysive Pharmaceuticals Inc.
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 27 Mar 2008
Discovery Labs Adds Two Executives to Its Management Team
Biopharmaceuticals Personnel
 HSMN NewsFeed - 27 Mar 2008
Pieris Raises EUR 25 M (US$ 38 M) in Series B Financing Round
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 27 Mar 2008
Positive Phase III Data Unveiled for New GnRH Blocker Degarelix
Biopharmaceuticals Urology
 HSMN NewsFeed - 27 Mar 2008
Novel Oral Anticoagulant Pradaxa(R) (dabigatran etexilate) Approved by the European Commission
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 26 Mar 2008
Shire and TAP Agree to Co-promote LIALDA(TM) (mesalamine), the First Oral Once-Daily Mesalamine for Patients With Active, Mild to Moderate Ulcerative Colitis
Biopharmaceuticals Gastroenterology
 HSMN NewsFeed - 26 Mar 2008
BioAlliance Pharma Receives Market Approval for Loramyc(R) in Germany, Belgium and Luxemburg
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 26 Mar 2008
Cangene's anti-hepatitis B product granted orphan-drug exclusive approval by the U.S. Food and Drug Administration
Biopharmaceuticals FDA
 HSMN NewsFeed - 26 Mar 2008
Aeterna Zentaris Begins Second Phase 3 Trial of Cetrorelix for Benign Prostatic Hyperplasia
Biopharmaceuticals Urology
 HSMN NewsFeed - 25 Mar 2008
Oncolin Therapeutics Provides a Company Overview
Biopharmaceuticals Oncology
 HSMN NewsFeed - 25 Mar 2008
Circulation Publishes Data Showing KYNAPID(TM) (Vernakalant Hydrochloride) Injection Rapidly Converted Short-Duration Atrial Fibrillation to Sinus Rhythm
Biopharmaceuticals Cardiology
 HSMN NewsFeed - 25 Mar 2008
Medivation Announces Senior Management Promotions
Biopharmaceuticals Personnel
 HSMN NewsFeed - 25 Mar 2008
Sirtris Pharmaceuticals Announces the Appointment of Paul A. Friedman, M.D., President and CEO of Incyte Corporation, to its Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 25 Mar 2008
Ceragenix Enters into Agreement to License CSA-54 and other Ceragenin Compounds To Biopharmaceutical Company for HIV and STD Applications
Biopharmaceuticals HIV/AIDS Licensing
 HSMN NewsFeed - 25 Mar 2008
APP Pharmaceuticals Launches Cefepime Hydrochloride for Injection
Biopharmaceuticals Generics
 HSMN NewsFeed - 25 Mar 2008
Sonus Pharmaceuticals Refines Strategic Initiatives
Biopharmaceuticals
 HSMN NewsFeed - 25 Mar 2008
ARCALYST(TM) (rilonacept), First and Only FDA-approved Treatment for Cryopyrin-Associated Periodic Syndromes (CAPS), Now Available in the United States
Biopharmaceuticals
 HSMN NewsFeed - 25 Mar 2008
Amrubicin(R) Receives FDA Orphan Drug Designation for the Treatment of Small Cell Lung Cancer
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 25 Mar 2008
Micromet Establishes New Scientific Advisory Board for Its BiTE Antibody Technology with Leading Experts in the Fields of Oncology, Immunotherapy and Drug Development
Biopharmaceuticals Personnel
 HSMN NewsFeed - 25 Mar 2008
Anesiva Commences Phase 3 Clinical Trial of Adlea(TM) for Reducing Post-Surgical Pain Following Bunionectomy
Biopharmaceuticals
 HSMN NewsFeed - 25 Mar 2008
Taro Receives FDA Approval for Ondansetron Hydrochloride Injection USP, 2 mg/mL ANDA
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 25 Mar 2008
Monogram Announces Promotion of Gordon Parry, PhD, to Vice President, Research and Development, Oncology
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 25 Mar 2008
Pharming signs distribution agreement for Rhucin(R) in Turkey
Biopharmaceuticals Distribution
 HSMN NewsFeed - 25 Mar 2008
Cell Therapeutics, Inc. (CTI) Announces Enrollment Complete in Phase III EXTEND (PIX301) Clinical Trial of Pixantrone in Patients With Second or Greater Relapse of Diffuse Large B Cell NHL
Biopharmaceuticals Oncology
 HSMN NewsFeed - 24 Mar 2008
Synthetic Blood International, Inc. Announces Passing of Interim CEO Robert Larsen
Biopharmaceuticals Personnel
 HSMN NewsFeed - 24 Mar 2008
Accentia Biopharmaceuticals Announces Results on Primary Endpoint in Clinical Study of SinuNase Lavage
Biopharmaceuticals
 HSMN NewsFeed - 24 Mar 2008
Corcept Therapeutics Announces Commencement of Next Phase 3 Study With CORLUX(R) for the Treatment of Psychotic Depression
Biopharmaceuticals
 HSMN NewsFeed - 24 Mar 2008
DSMB Again Supports Continuation of the Phase III Clinical Trial of Medidur(TM) FA for the Treatment of DME
Biopharmaceuticals
 HSMN NewsFeed - 24 Mar 2008
BARACLUDE(R) (entecavir) Data Continue to Demonstrate Low Incidence of Resistance Through Five Years of Treatment in Nucleoside-naive Chronic Hepatitis B Patients
Biopharmaceuticals
 HSMN NewsFeed - 24 Mar 2008
Acura Pharmaceuticals, Inc. Names Robert B. Jones Chief Operating Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 24 Mar 2008
First Patient Successfully Undergoes Breakthrough Treatment for Acute Myocardial Infarction Developed by BioLineRx
Biopharmaceuticals Cardiology
 HSMN NewsFeed - 24 Mar 2008
Pro-Pharmaceuticals Announces DAVANAT(R) Regimen Approved to Treat Breast Cancer Patient
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 24 Mar 2008
Depomed Doses First Patient in New Phase 3 Clinical Trial of Gabapentin GR in Postherpetic Neuralgia
Biopharmaceuticals
 HSMN NewsFeed - 21 Mar 2008
E-Z-EM, Inc. Stockholders Approve Merger Agreement
Biopharmaceuticals Radiology Mergers & Acquisitions
 HSMN NewsFeed - 21 Mar 2008
Opexa Therapeutics Announces Retirement of CEO David McWilliams
Biopharmaceuticals Personnel
 HSMN NewsFeed - 21 Mar 2008
Mentor Corporation Announces FDA Approval of Prevelle Silk: First Dermal Filler to Prove Pain Reduction in the U.S.
Biopharmaceuticals FDA Dermatology
 HSMN NewsFeed - 20 Mar 2008
Federal Court of Appeal in Canada Upholds Lipitor Enantiomer Patent, Decision Prevents Launch of Generic Product by Ranbaxy until 2010
Biopharmaceuticals Generics Litigation
 HSMN NewsFeed - 20 Mar 2008
International ACTEMRA Rheumatoid Arthritis Study Highlighted in The Lancet
Biopharmaceuticals
 HSMN NewsFeed - 20 Mar 2008
Perioperative Eloxatin(R)-Based Regimen Significantly Reduced the Risk of Relapse Versus Surgery Alone in Eligible Colorectal Cancer Patients with Initially Resectable Liver Metastases
Biopharmaceuticals Oncology
 HSMN NewsFeed - 20 Mar 2008
Stem Cell Technology Offers Promise of Huge Savings for Drug Developers
Biopharmaceuticals Regenerative Medicine
 HSMN NewsFeed - 20 Mar 2008
CHMP Upholds Negative Opinion for the EU Application for Cimzia(R) in the Treatment of Crohn's Disease
Biopharmaceuticals Gastroenterology Regulatory
 HSMN NewsFeed - 20 Mar 2008
Immunomedics Develops New Immunoconjugates for Targeted Chemotherapy of Pancreatic and Other Cancers
Biopharmaceuticals Oncology
 HSMN NewsFeed - 20 Mar 2008
EpiCept Announces Opinion by European Regulatory Authority on Ceplene(R)
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 20 Mar 2008
Cephalon Receives FDA Approval for TREANDA, a Novel Chemotherapy for Chronic Lymphocytic Leukemia
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 20 Mar 2008
Presidio Pharmaceuticals Obtains Exclusive Worldwide Rights to XTL Biopharmaceuticals Ltd. Hepatitis C Virus (HCV) NS5A Program
Biopharmaceuticals Licensing
 HSMN NewsFeed - 20 Mar 2008
Zelos Therapeutics Appoints David S. Krause, MD, FACP, as Chief Medical Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 20 Mar 2008
XTL Biopharmaceuticals Signs $108 Million Deal for the Licensing of its Pre- Clinical Program in Hepatitis C to Presidio Pharmaceuticals
Biopharmaceuticals Licensing
 HSMN NewsFeed - 20 Mar 2008
Pharming to receive Negative Opinion on European Marketing Authorization Application for Rhucin(R)
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 20 Mar 2008
UCB advises US-physicians to down-titrate patients on Neupro(R) in view of out-of-stock situation in the US
Biopharmaceuticals Neurology Product Recall
 HSMN NewsFeed - 19 Mar 2008
Icagen Announces Senior Management Promotions
Biopharmaceuticals Personnel
 HSMN NewsFeed - 19 Mar 2008
Takeda Announces New U.S. Leadership
Biopharmaceuticals Personnel
 HSMN NewsFeed - 19 Mar 2008
Takeda, Abbott Announce Plans to Conclude TAP Joint Venture
Biopharmaceuticals
 HSMN NewsFeed - 19 Mar 2008
Genzyme Withdraws Bioenvision's European Filing of Evoltra(R) in Elderly AML Patients
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 19 Mar 2008
Samaritan Pharmaceuticals Acquires Commercialization Rights to Market and Distribute Abiogen's Cancer Drug Abioklad in Greece, Cyprus and Turkey
Biopharmaceuticals Distribution
 HSMN NewsFeed - 19 Mar 2008
Alkermes Announces Restructuring
Biopharmaceuticals
 HSMN NewsFeed - 19 Mar 2008
Forest Laboratories Announces Resignation of Ivan Gergel, MD
Biopharmaceuticals Personnel
 HSMN NewsFeed - 19 Mar 2008
Supplemental Application for GARDASIL(R), Merck's Cervical Cancer Vaccine, Designated Priority Review by the U.S. FDA for Use in Women 27 through 45
Biopharmaceuticals
 HSMN NewsFeed - 19 Mar 2008
BioSante Pharmaceuticals Initiates Third LibiGel(R) Phase III Trial in the Treatment of Female Sexual Dysfunction under an SPA
Biopharmaceuticals
 HSMN NewsFeed - 19 Mar 2008
Merck Serono Launches Cyanokit(R) in Japan
Biopharmaceuticals
 HSMN NewsFeed - 19 Mar 2008
Akorn-Strides, LLC Announces FDA Approval for Fosphenytoin Sodium Injection USP, 100 mg/2mL and 500 mg/10mL
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 19 Mar 2008
Diamyd(R) Diabetes Vaccine Receives Approval to Start Phase III Trials in Europe
Biopharmaceuticals Endocrinology Regulatory
 HSMN NewsFeed - 18 Mar 2008
Statement by InterMune, Inc. Regarding Justice Department Action Against Former Employee for Past Conduct
Biopharmaceuticals Litigation
 HSMN NewsFeed - 18 Mar 2008
960-Patient Study Demonstrates Zero Blood Stream Infection In Patients Treated With Angiotech's Novel 5-FU Central Venous Catheter
Devices Biopharmaceuticals
 HSMN NewsFeed - 18 Mar 2008
LigoCyte Pharmaceuticals Finalizes Agreement for $28M Series 'C' Financing Round
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 18 Mar 2008
Cardinal Health, GE Healthcare Broaden Relationship to Offer Greater Access to Myoview(TM) Imaging Agent
Biopharmaceuticals Radiology
 HSMN NewsFeed - 18 Mar 2008
Centocor, Inc. and Schering-Plough Submit Application Requesting Approval of Golimumab in Europe for the Treatment of Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 18 Mar 2008
Immunomedics' Milatuzumab Receives FDA Orphan Drug Designation for Therapy of Multiple Myeloma
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 18 Mar 2008
Alimera Sciences Closes $30 Million in Series C Financing, Increasing Stake in Medidur(TM) FA
Biopharmaceuticals Venture Capital Ophthalmology
 HSMN NewsFeed - 18 Mar 2008
Worldwide Leader in Diagnostic Medicine is Launched as Lantheus Medical Imaging
Biopharmaceuticals Radiology
 HSMN NewsFeed - 18 Mar 2008
Cardinal Health Names Former Acting Deputy U.S. Attorney General Craig S. Morford to Chief Compliance Officer Post
Biopharmaceuticals Personnel
 HSMN NewsFeed - 18 Mar 2008
Stellar Pharmaceuticals Inc. Announces the Receipt Of Their First Order for Neovisc(R) Going to Torrex Chiesi Pharma GmbH
Biopharmaceuticals Distribution
 HSMN NewsFeed - 18 Mar 2008
FDA Issues Approvable Letter for Ceftobiprole for Treatment of Complicated Skin Infections
Biopharmaceuticals FDA
 HSMN NewsFeed - 18 Mar 2008
FDA issues Approvable Letter for ceftobiprole, a new anti-MRSA broad-spectrum antibiotic
Biopharmaceuticals FDA
 HSMN NewsFeed - 18 Mar 2008
BioNumerik Pharmaceuticals and ASKA Pharmaceutical Co. Announce Results from Phase III Clinical Trial of Tavocept(TM)
Biopharmaceuticals Oncology
 HSMN NewsFeed - 17 Mar 2008
Zogenix Licenses European Development and Commercial Rights for sumatriptan DosePro(TM) to Desitin Pharmaceuticals, GmbH
Biopharmaceuticals Drug Delivery Licensing
 HSMN NewsFeed - 17 Mar 2008
Dynavax and Merck & Co., Inc. Report Clinical Hold of Investigational Vaccine HEPLISAV
Biopharmaceuticals
 HSMN NewsFeed - 17 Mar 2008
Nuvelo Announces Phase 2 SONOMA-3 Trial Did Not Meet Target Product Profile and Discontinues Alfimeprase Development
Biopharmaceuticals
 HSMN NewsFeed - 17 Mar 2008
NPS Reports Successful GATTEX(TM) Extension Study
Biopharmaceuticals Gastroenterology
 HSMN NewsFeed - 17 Mar 2008
QLT announces positive FDA action on Aczone(TM)
Biopharmaceuticals
 HSMN NewsFeed - 17 Mar 2008
enGene Inc. Completes US$6.4M Series A Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 17 Mar 2008
Corcept Therapeutics Announces $25.3 Million Private Equity Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 17 Mar 2008
Amgen and Wyeth Announce Updates to U.S. Prescribing Information for Enbrel(R)
Biopharmaceuticals
 HSMN NewsFeed - 17 Mar 2008
Tianyin Pharmaceutical Announces SFDA Approval to Market Azithromycin Dispersible Tablets
Biopharmaceuticals Generics Regulatroy
 HSMN NewsFeed - 17 Mar 2008
Oculus Innovative Sciences Announces Positive Results From Three Abstracts Evaluating the Use of Microcyn(R) Technology in Diabetic Foot Ulcers
Biopharmaceuticals Wound Care
 HSMN NewsFeed - 17 Mar 2008
FDA Indicates That Genasense(R) Approval in Chronic Lymphocytic Leukemia Will Require Additional Confirmatory Data
Biopharmaceuticals Oncology
 HSMN NewsFeed - 17 Mar 2008
Abraxis Bioscience Announces Filing of Marketing Application in Japan for ABRAXANE in the Treatment of Breast Cancer
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 17 Mar 2008
Avalon Pharmaceuticals Appoints Philip Frost, M.D., Ph.D., to Its Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 17 Mar 2008
Cytomedix Appoints Martin P. Rosendale Executive Vice President and Chief Operating Officer
Biopharmaceuticals Wound Care Personnel
 HSMN NewsFeed - 17 Mar 2008
Hollis-Eden Pharmaceuticals Provides Update on Clinical Development Program; Announces Fourth Quarter and Year-End 2007 Financial Results
Biopharmaceuticals
 HSMN NewsFeed - 17 Mar 2008
Sepracor Presents OMNARIS(TM) HFA Nasal Aerosol Large-Scale Phase II Study Data at American Academy of Allergy Asthma and Immunology (AAAAI)
Biopharmaceuticals
 HSMN NewsFeed - 17 Mar 2008
Sepracor Presents Safety Data on OMNARIS(TM)AQ and OMNARIS(TM) HFA Nasal Sprays at American Academy of Allergy Asthma and Immunology (AAAAI)
Biopharmaceuticals
 HSMN NewsFeed - 17 Mar 2008
Data Presented at International Psoriasis Meeting Support Potential New Role for Biologic Treatment Etanercept in Management of Childhood Psoriasis
Biopharmaceuticals Dermatology
 HSMN NewsFeed - 17 Mar 2008
Fludarabine, Mitoxantrone and Zevalin(R) Produces 96% Complete Remission Rate in First-Line Treatment of Patients with Follicular Non-Hodgkin's Lymphoma
Biopharmaceuticals Oncology
 HSMN NewsFeed - 14 Mar 2008
Biologics, Dermal Fillers are Key to Dermatological Drug Market Growth
Devices Biopharmaceuticals Dermatology
 HSMN NewsFeed - 14 Mar 2008
FDA Gives Go Ahead for Actavis' Irinotecan Hydrochloride Injection
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 14 Mar 2008
Greer Launches Phase III Trial to Study Efficacy of Sublingual-Oral Immunotherapy in Patients with Allergic Rhinoconjunctivitis
Biopharmaceuticals
 HSMN NewsFeed - 14 Mar 2008
Genentech Provides Business Update at Annual Investment Community Meeting
Biopharmaceuticals Oncology
 HSMN NewsFeed - 14 Mar 2008
Isolagen, Inc. Completes Enrollment in Isolagen Therapy(TM) Phase II/III Acne Scar Study
Biopharmaceuticals Dermatology
 HSMN NewsFeed - 14 Mar 2008
Diamyd Medical: Diamyd Gets Authorization to Begin Phase III Study in the US
Biopharmaceuticals Endocrinology
 HSMN NewsFeed - 13 Mar 2008
Lilly and Transition Therapeutics Announce Licensing and Collaboration Agreement
Biopharmaceuticals Licensing
 HSMN NewsFeed - 13 Mar 2008
EntreMed Announces 2008 Corporate and Clinical Program Priorities
Biopharmaceuticals Oncology
 HSMN NewsFeed - 13 Mar 2008
Salix Acquires Budesonide Products from Dr. Falk Pharma
Biopharmaceuticals Licensing
 HSMN NewsFeed - 13 Mar 2008
Hawthorn Pharmaceuticals, Inc. Receives FDA Approval on Granisol(TM) Oral Solution
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 13 Mar 2008
Proteon Therapeutics Appoints Experienced Biopharmaceutical Executive, Gregory D. Phelps to its Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 13 Mar 2008
Teva Provides Update on Glatiramer Acetate 40mg for Amyotrophic Lateral Sclerosis (ALS)
Biopharmaceuticals Neurology
 HSMN NewsFeed - 13 Mar 2008
Juvaris BioTherapeutics, Inc. Announces the Appointment of Grant E. Pickering as Chief Executive Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 13 Mar 2008
Sequence of Treatments May Induce Clinical Response in Metastatic Renal Cell Carcinoma Patients
Biopharmaceuticals Oncology
 HSMN NewsFeed - 13 Mar 2008
Cardinal Health Names Michael C. Kaufmann to Lead Pharmaceutical Segment
Biopharmaceuticals Personnel
 HSMN NewsFeed - 13 Mar 2008
Novelos Therapeutics Reaches Target Enrollment in Pivotal Phase 3 Lung Cancer Trial
Biopharmaceuticals Oncology
 HSMN NewsFeed - 13 Mar 2008
Amgen to Discuss Benefits and Risks of ESA Treatment for Cancer Patients with Anemia Due to Chemotherapy at FDA ODAC Meeting
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 13 Mar 2008
SeraCare Life Sciences Appoints Vice President of Business Development
Biopharmaceuticals Personnel
 HSMN NewsFeed - 13 Mar 2008
Sagent Pharmaceuticals Launches Cefazolin for Injection, USP
Biopharmaceuticals Generics
 HSMN NewsFeed - 13 Mar 2008
Sciele Pharma Acquires Twinject(R) Epinephrine Auto-Injector from Verus Pharmaceuticals
Biopharmaceuticals Acquisitions
 HSMN NewsFeed - 13 Mar 2008
Publication of Clinical Results Underscores VELCADE(R) (Bortezomib) For Injection Based Therapy As a Standard of Care In Newly Diagnosed Multiple Myeloma Patients
Biopharmaceuticals Oncology
 HSMN NewsFeed - 13 Mar 2008
Neurochem moves eprodisate (KIACTA(TM)) drug development program forward for Amyloid A amyloidosis
Biopharmaceuticals
 HSMN NewsFeed - 13 Mar 2008
Clinical Data, Inc. Initiates Second Pivotal Phase III Study of Vilazodone
Biopharmaceuticals
 HSMN NewsFeed - 13 Mar 2008
AVI BioPharma Announces Acquisition of Ercole Biotech
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 12 Mar 2008
Statement from Eli Lilly and Company: Response to Connecticut Attorney General News Release
Biopharmaceuticals
 HSMN NewsFeed - 12 Mar 2008
Immtech Announces Update on Business Operations
Biopharmaceuticals
 HSMN NewsFeed - 12 Mar 2008
Barr Receives Approval for Generic Taxol(R) Injection USP, 6mg/mL
Biopharmaceuticals Generics Oncology FDA
 HSMN NewsFeed - 12 Mar 2008
Amgen Statement on Successful Outcome of Romiplostim Panel Meeting
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 12 Mar 2008
EyeGate Pharma Secures $15M in Series C Venture Funding
Biopharmaceuticals Ophthalmology Venture Capital
 HSMN NewsFeed - 12 Mar 2008
AstraZeneca Completes Enrollment in Two Pivotal Phase III Studies of the Investigational Drug Vandetanib (ZACTIMA(R)) in Non-Small Cell Lung Cancer (NSCLC)
Biopharmaceuticals Oncology
 HSMN NewsFeed - 12 Mar 2008
Endo Pharmaceuticals Names David P. Holveck President and Chief Executive Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 12 Mar 2008
Celsion Commences Global Phase III Study for Primary Liver Cancer
Biopharmaceuticals Oncology
 HSMN NewsFeed - 12 Mar 2008
FDA Agrees to Amend Dendreon's Special Protocol Assessment for Phase 3 IMPACT Study of PROVENGE
Biopharmaceuticals Oncology
 HSMN NewsFeed - 12 Mar 2008
Memory Pharmaceuticals Refocuses to Advance Development and Clinical Programs
Biopharmaceuticals
 HSMN NewsFeed - 12 Mar 2008
Wyeth and Progenics Provide Update on Phase 3 Clinical Trial of Intravenous Methylnaltrexone for Postoperative Ileus
Biopharmaceuticals
 HSMN NewsFeed - 12 Mar 2008
More Clinical Data Required to Support European Approval of Desvenlafaxine as a Potential Treatment for Vasomotor Symptoms
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 11 Mar 2008
FDA Advisory Committee Unanimously Recommends U.S. Approval of Sugammadex, the First and Only Selective Relaxant Binding Agent
Biopharmaceuticals FDA
 HSMN NewsFeed - 11 Mar 2008
Pfizer's Waxman to Leave
Biopharmaceuticals Personnel
 HSMN NewsFeed - 11 Mar 2008
Bayer HealthCare Pharmaceuticals Introduces VistaTrak(TM) an Innovative Contrast Media Management System
Biopharmaceuticals Devices Radiology
 HSMN NewsFeed - 11 Mar 2008
Cerner and UNMHSC Sign Agreement to Evaluate Dry-Powder Inhaler Drug-Delivery Technology
Biopharmaceuticals Drug Delivery
 HSMN NewsFeed - 11 Mar 2008
Schering-Plough Announces Filing of U.S. Application for OTC ZEGERID(R)
Biopharmaceuticals FDA
 HSMN NewsFeed - 11 Mar 2008
Santarus Announces Submission of New Drug Application by Schering-Plough for ZEGERID Branded OTC Product
Biopharmaceuticals FDA
 HSMN NewsFeed - 11 Mar 2008
Totality of Available Data Reaffirms PROCRIT(R) (Epoetin alfa) Is Safe and Effective When Used Appropriately as Labeled to Treat Chemotherapy-Induced Anemia
Biopharmaceuticals FDA
 HSMN NewsFeed - 11 Mar 2008
Pipex Pharmaceuticals Announces Cost Reduction Measures
Biopharmaceuticals Neurology
 HSMN NewsFeed - 11 Mar 2008
EUSA Pharma to Acquire US Specialty Oncology Company Cytogen
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 11 Mar 2008
Peregrine Pharmaceuticals Announces Positive Data From Cotara(R) Brain Cancer Trials
Biopharmaceuticals Oncology
 HSMN NewsFeed - 10 Mar 2008
Femara(R) helps protect against return of breast cancer even when treatment starts several years after completing tamoxifen therapy
Biopharmaceuticals Oncology
 HSMN NewsFeed - 10 Mar 2008
XOMA Appoints Mary L. Anderson as Vice President of Business Development
Biopharmaceuticals Personnel
 HSMN NewsFeed - 10 Mar 2008
ZARS Pharma Announces Worldwide License Agreement With Galderma Pharma S.A. for Pliaglis(TM), a Topical Local Anesthetic
Biopharmaceuticals Licensing
 HSMN NewsFeed - 10 Mar 2008
Argolyn Bioscience Grows Management Team
Biopharmaceuticals Personnel
 HSMN NewsFeed - 10 Mar 2008
Symbollon Pharmaceuticals Signs Term Sheet to Acquire Chinese Pharmaceutical Company
Biopharmaceuticals
 HSMN NewsFeed - 10 Mar 2008
Javelin Pharmaceuticals' Dyloject Accepted by Scottish Medicines Consortium (SMC)
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 10 Mar 2008
Amerinet Launches Generic Sourcing Program to Reduce Pharmacy Spend
Biopharmaceuticals Generics Group Purchasing
 HSMN NewsFeed - 10 Mar 2008
Alcon Announces Leadership Change to Research and Development Organization
Biopharmaceuticals Ophthalmology Personnel
 HSMN NewsFeed - 10 Mar 2008
GSK Cervical Cancer Candidate Vaccine CERVARIX (R) Demonstrates Long-Term Protection for More Than Six Years
Biopharmaceuticals Oncology
 HSMN NewsFeed - 10 Mar 2008
Auriga Laboratories Announces FDA Approval of Liquadd(TM) (Dextroamphetamine Sulfate) Oral Solution for the Treatment of ADHD and Upcoming Product Launch
Biopharmaceuticals FDA
 HSMN NewsFeed - 10 Mar 2008
Elusys Therapeutics Appoints Robert Gundel as Vice President of Research
Biopharmaceuticals Personnel
 HSMN NewsFeed - 10 Mar 2008
BrainCells Inc. Completes $30 Million Initial Closing of Series B Financing
Biopharmaceuticals Neurology Venture Capital Personnel
 HSMN NewsFeed - 10 Mar 2008
Curis Announces Conclusion of Hedgehog Agonist Collaboration with Wyeth
Biopharmaceuticals
 HSMN NewsFeed - 10 Mar 2008
Keryx Biopharmaceuticals Announces that SUN-MICRO Phase 3 Clinical Trial Fails to Meet Primary Efficacy Endpoint
Biopharmaceuticals Endocrinology
 HSMN NewsFeed - 10 Mar 2008
OREXIGEN(TM) Therapeutics Appoints Carol Baum as Vice President of Commercialization
Biopharmaceuticals Personnel
 HSMN NewsFeed - 10 Mar 2008
Labopharm Initiates Phase III Clinical Trial for Twice-Daily Formulation of Tramadol-Acetaminophen
Biopharmaceuticals
 HSMN NewsFeed - 10 Mar 2008
Anesiva Announces Submission of Supplemental New Drug Application for Zingo(TM) to Reduce Pain Associated With Needle Insertion Procedures in Adults
Biopharmaceuticals
 HSMN NewsFeed - 10 Mar 2008
Wyeth to Invest $280 Million to Build State-of-the-Art Nutritional Manufacturing Facility in China
Biopharmaceuticals
 HSMN NewsFeed - 8 Mar 2008
Ortho Biotech Modifies Prescribing Information for PROCRIT(R) (Epoetin alfa)
Biopharmaceuticals
 HSMN NewsFeed - 7 Mar 2008
Keryx Biopharmaceuticals Announces that the SUN-MICRO Phase 3 Clinical Trial Failed to Meet its Primary Efficacy Endpoint
Biopharmaceuticals Endocrinology
 HSMN NewsFeed - 7 Mar 2008
Alkermes Receives Notice from Eli Lilly Terminating Inhaled Insulin Program
Biopharmaceuticals Drug Delivery Endocrinology
 HSMN NewsFeed - 7 Mar 2008
FDA Approves New Drug Application (NDA) for LEVOleucovorin, Spectrum's First Proprietary Oncology Drug
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 7 Mar 2008
Lilly Announces Termination of AIR Insulin Program
Biopharmaceuticals Endocrinology Drug Delivery
 HSMN NewsFeed - 7 Mar 2008
Amgen Announces Update to U.S. Prescribing Information for Aranesp(R) and EPOGEN(R)
Biopharmaceuticals FDA
 HSMN NewsFeed - 7 Mar 2008
Celgene Completes $2.9 Billion Acquisition of Pharmion
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 7 Mar 2008
Pfizer Wins Challenge to Two Main U.S. Patents for Celebrex by Generic Manufacturer Teva
Biopharmaceuticals Generics Litigation
 HSMN NewsFeed - 7 Mar 2008
Galderma Pharma, S.A. and ZARS Pharma, Inc. Extend Agreement to Cover Worldwide Rights for Pliaglis(TM)
Biopharmaceuticals Distribution
 HSMN NewsFeed - 7 Mar 2008
In Post-Vioxx Era, Biologics Are Reviving Arthritis Treatment Market
Biopharmaceuticals
 HSMN NewsFeed - 7 Mar 2008
Alkermes Provides Update on Inhaled Insulin Program
Biopharmaceuticals Drug Delivery Endocrinology
 HSMN NewsFeed - 7 Mar 2008
Gilead Sciences Submits Marketing Authorisation Application for Aztreonam Lysine 75 mg Powder for Nebuliser Solution, a Potential New Treatment for Cystic Fibrosis, to European Medicines Agency
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 7 Mar 2008
Genta Announces Licensing Agreement for Worldwide Development and Commercialization of a Leading Oral Taxane, Tesetaxel
Biopharmaceuticals Licensing Oncology
 HSMN NewsFeed - 7 Mar 2008
Abbott to Collaborate With Genentech, Roche and OSI on Molecular Test for Lung Cancer Therapy Response
Diagnostics Biopharmaceuticals Oncology
 HSMN NewsFeed - 7 Mar 2008
Cortex Receives Approval from German Regulatory Authority to Proceed with Two Clinical Trials for AMPAKINE(R) CX717 for the Acute Treatment of Respiratory Depression Due to Opiate Analgesics
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 7 Mar 2008
Orexo: Rapinyl(TM) has Received Swedish Marketing Authorization
Biopharmaceuticals Regulatory Drug Delivery
 HSMN NewsFeed - 6 Mar 2008
Gilead Appoints Dr. John J. Toole as Senior Vice President, Corporate Development
Biopharmaceuticals Personnel
 HSMN NewsFeed - 6 Mar 2008
Office of Naval Research Provides $3.5 Million in New Grants for Clinical Research Involving Synthetic Blood International's Oxycyte(R)
Biopharmaceuticals
 HSMN NewsFeed - 6 Mar 2008
CSL Behring Submits BLA Requesting Approval of C1-Esterase Inhibitor for the Treatment of Hereditary Angioedema
Biopharmaceuticals
 HSMN NewsFeed - 6 Mar 2008
Genzyme Launches Renvela(R) in the U.S. for Dialysis Patients
Biopharmaceuticals
 HSMN NewsFeed - 6 Mar 2008
inVentiv Selling Solutions Selected to Provide Sales Team for Cephalon Inc.
Biopharmaceuticals
 HSMN NewsFeed - 6 Mar 2008
Morphotek(R) Signs Exclusive Licensing Agreement for Anti-Cancer Antibody
Biopharmaceuticals Licensing
 HSMN NewsFeed - 6 Mar 2008
Onset Therapeutics Announces Launch of Anestafoam(TM), a Novel Topical Anesthetic Foam
Biopharmaceuticals Drug Delivery
 HSMN NewsFeed - 6 Mar 2008
IMPAX Comments on Lawsuit Related to Generic Version of Detrol LA(R)
Biopharmaceuticals Generics Litigation
 HSMN NewsFeed - 5 Mar 2008
Kyowa Hakko and Amgen Enter Licensing Agreement for Anti-CCR4 Humanized Monoclonal Antibody
Biopharmaceuticals Licensing
 HSMN NewsFeed - 5 Mar 2008
FDA Accepts for Review Theravance's Complete Response to Approvable Letter for Telavancin for the Treatment of Complicated Skin and Skin Structure Infections
Biopharmaceuticals FDA
 HSMN NewsFeed - 5 Mar 2008
TOPIGEN Pharmaceuticals Announces Management Changes
Biopharmaceuticals Personnel
 HSMN NewsFeed - 5 Mar 2008
Barr Subsidiary Sues Watson for SEASONIQUE(R) Patent Infringement
Biopharmaceuticals Litigation
 HSMN NewsFeed - 5 Mar 2008
Vitae Pharmaceuticals Appoints Richard Gregg, M.D. as Chief Scientific Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 5 Mar 2008
Pfizer Presents New Opportunities for Global Growth
Biopharmaceuticals
 HSMN NewsFeed - 5 Mar 2008
Bristol-Myers Squibb Board Elects Jean-Marc Huet Senior Vice President and Chief Financial Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 5 Mar 2008
Trevena, Inc. Announces $24 Million Series A Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 5 Mar 2008
PanGenetics Raises 23 Million Euro in Series C Financing to Fund Clinical Advancement of Its Therapeutic Antibody Programs
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 5 Mar 2008
EU Commission Approves Updated Prescribing Information for Aranesp(R)
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 5 Mar 2008
New 300mg Loading Dose Tablet for Plavix(R) Receives Positive Opinion From the European Committee for Medicinal Products (CHMP)
Biopharmaceuticals Cardiology Regulatory
 HSMN NewsFeed - 5 Mar 2008
CHOP-Zevalin(R) Investigational Regimen Produces 95% Complete Remission and 75% Estimated Two Year Progression-Free Survival in Elderly Patients with Diffuse Large B-cell Lymphoma
Biopharmaceuticals Oncology
 HSMN NewsFeed - 4 Mar 2008
Javelin Pharmaceuticals Board Appoints Industry Veteran Martin Driscoll as Chief Executive Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 4 Mar 2008
Roche Statement Regarding Tamiflu U.S. Label Revision
Biopharmaceuticals FDA
 HSMN NewsFeed - 4 Mar 2008
Momenta Pharmaceuticals Appoints Dr. James M. Roach as Chief Medical Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 4 Mar 2008
Maxygen Announces Management Changes
Biopharmaceuticals Personnel
 HSMN NewsFeed - 4 Mar 2008
Bayer HealthCare and Juvaris BioTherapeutics Announce Major Licensing Agreement
Biopharmaceuticals Licensing
 HSMN NewsFeed - 4 Mar 2008
Targanta Strengthens Senior Management Team
Biopharmaceuticals Personnel
 HSMN NewsFeed - 4 Mar 2008
Cell Therapeutics, Inc. (CTI) Submits European Marketing Authorization Application for XYOTAX(TM)
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 4 Mar 2008
UCB: Early Data on Cimzia(R) from the WELCOME Study Show Efficacy in Infliximab-Refractory Crohn's Disease Patients
Biopharmaceuticals Gastroenterology
 HSMN NewsFeed - 3 Mar 2008
Barr Announces Favorable Ruling in Yasmin(R) Patent Challenge
Biopharmaceuticals Litigation
 HSMN NewsFeed - 3 Mar 2008
Indevus Pharmaceuticals Announces Retirement Plans For Its CEO and Chairman
Biopharmaceuticals Personnel
 HSMN NewsFeed - 3 Mar 2008
Pfizer Names William Ringo Senior Vice President of Strategy and Business Development
Biopharmaceuticals Personnel
 HSMN NewsFeed - 3 Mar 2008
Vasogen Provides Update on ACCLAIM II Program
Biopharmaceuticals Cardiology
 HSMN NewsFeed - 3 Mar 2008
FDA Grants Priority Review for PROMACTA(R) (eltrombopag)
Biopharmaceuticals FDA
 HSMN NewsFeed - 3 Mar 2008
Pfizer to Acquire Serenex to Extend Oncology Pipeline and Access Novel Technology Platform
Biopharmaceuticals Oncology Mergers & Acquisitions
 HSMN NewsFeed - 3 Mar 2008
ZIOPHARM Appoints Steven Bloom as Vice President, Business Development and Barry Jones, Ph.D., as Senior Vice President, Preclinical Operations
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 3 Mar 2008
Endo Pharmaceuticals to Launch Three New Dosage Strengths of OPANA(R) ER
Biopharmaceuticals Pain Management FDA
 HSMN NewsFeed - 3 Mar 2008
Pro-Pharmaceuticals DAVANAT(R) Extends Median Survival 6.7 Months for End-Stage Colorectal Cancer Patients After All Other Treatments Failed
Biopharmaceuticals Oncology
 HSMN NewsFeed - 3 Mar 2008
Emergent BioSolutions Appoints Dr. W. James Jackson as Chief Scientific Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 3 Mar 2008
AEterna Zentaris and Paladin Labs Announce Sale and Purchase of Miltefosine Rights
Biopharmaceutical Acquisitions
 HSMN NewsFeed - 3 Mar 2008
GTx Announces Additional Top Line Phase III Data Demonstrating Toremifene Citrate 80 mg Reduced Hot Flashes in Men with Prostate Cancer on Androgen Deprivation Therapy
Biopharmaceuticals Oncology
 HSMN NewsFeed - 3 Mar 2008
Crucell Announces Vaccine Development Agreement with Wyeth Pharmaceuticals
Biopharmaceuticals
 HSMN NewsFeed - 3 Mar 2008
Changes in UCB's Executive Committee
Biopharmaceuticals Personnel
 HSMN NewsFeed - 2 Mar 2008
FDA Approves Aloxi(R) (Palonosetron HCL) Injection for Prevention of Postoperative Nausea and Vomiting
Biopharmaceuticals FDA
Older Biopharmaceutical stories   Return to NewsFeed  
FindReps - screen and connect with rep candidates anonymously, in real time.

FindReps: Screen and connect with Medical Sales Rep candidates (Direct Reps and Independents) – anonymously, in real time.


RepJobs - Job Opportunities for Direct Sales Reps and New Product Lines for Independents!

RepJobs: Job Opportunities for Direct Sales Reps and New Product Lines for Independents!